The dtect<em>Dx</em> Breast Test for Breast Cancer

Article

Meredith C. Henderson, PhD, Head, R&D, Provista Diagnostics, describes the dtectDx Breast test.

Meredith C. Henderson, PhD, Head, R&D, Provista Diagnostics, describes the dtectDxBreast test.

DtectDxBreast is essentially a blood test for the detection of breast cancer and is meant to be used in conjunction with mammography. With this test, Henderson says, information is available for a physician to make a decision regarding further imaging or biopsying.

DtectDxBreast is especially beneficial for women under 50 years, who tend to be underserved by mammography. The test is also beneficial, Henderson says, as it should not be affected by dense breast tissue or previous biopsy. If imaging is difficult or confounding in a patient, an empirical value from the dtectDxBreast test is still possible.

Clinical Pearls

  • The dtectDxBreast test is a blood test for the detection of breast cancer, meant to be used in conjunction with mammography
  • Especially beneficial for women under 50 years, who tend to be underserved by mammography
Related Videos
Video 5 - "Second-Line Treatment Considerations and Improving Outcomes in Breast Cancer"
Video 4 - "Impressions on Safety Data from EMERALD Subgroup Analysis"
Video 2 - "Importance of Biomarker Testing in Breast Cancer"
Video 3 - "EMERALD: Elacestrant for ER+/HER2- Advanced Breast Cancer"
Video 1 - "Patient Profile: A 49-Year-Old Woman with HR+/HER2- mBC and Liver and Lung Metastases"
Video 7 - "Unmet Needs and Future Directions in HER2+ Breast Cancer"
Video 6 - "Current Approaches to Treatment Sequencing in HER2+ Breast Cancer"
Video 5 - "Exciting Developments in HER2+ Breast Cancer"
Related Content